BM stem cells and cardiac repair: Where do we stand in 2004?

Cytotherapy

Volumn 7, Issue 1, 2005, Pages 3-15

  Orlic, D ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Infarction; Ischemia; Myocardial regeneration; Plasticity; Stem cell

Indexed keywords

CYCLOSPORIN A; ENHANCED GREEN FLUORESCENT PROTEIN; METHYLPREDNISOLONE; TECHNETIUM 99M;

ACCURACY; ACUTE HEART INFARCTION; AUTOLOGOUS STEM CELL TRANSPLANTATION; AUTOPSY; CELL ACTIVITY; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL FUSION; CELL INFILTRATION; CELL LABELING; CELL MIGRATION; CELL RENEWAL; CELL TRANSFER; CELL TRANSPLANTATION; CELL TRANSPORT; CLINICAL TRIAL; CORONARY STENT; DISEASE MODEL; DOG; DONOR; EMBRYONIC STEM CELL; GENETIC ANALYSIS; GRAFT REJECTION; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; MICROSCOPY; MITOSIS; MONITORING; MOUSE; MYOBLAST; NON INVASIVE MEASUREMENT; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PLASTICITY; PRIMATE; QUALITY CONTROL; RAT; REVIEW; RISK ASSESSMENT; STEM CELL; SWINE; TECHNOLOGY; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR;

EID: 17444388007     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240510018028     Document Type: Review

References (126)

1. Ferrari G, Cusella-DeAngelis G, Colletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-30.
2. Gussoni E, Soneoka Y, Strickland CD et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-4.
3. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multi-nucleate muscle fiber in response to injury. Cell 2002;111:589-601.
4. Doyonnas R, LaBarge MA, Sacco A et al. Hematopoietic contribution to skeletal muscle regeneration by myelomonocytic precursors. Proc Natl Acad Sci USA 2004;101: 13507-12.
5. Lagasse E, Connors H, Al Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
6. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-77.
7. Kale S, Karihaloo A, Clark PR et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112:42-9.
8. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-82.
9. Weimann JM, Charlton CA, Brazelton TR et al. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 2003;100: 2088-93.
10. Tomita S, Li R-K, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100(suppl):II247-56.
11. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
12. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-5.
13. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002;416:545-8.
14. Alvares-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-73.
15. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone marrow-derived hepatocytes. Nature 2003;422:897-901.
16. Vassilopoulos G, Wang P, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-4.
17. Camargo FD, Finegold M, Goodell MA. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 2004;113:1266-71.
18. Willenbring H, Bailey AS, Foster M et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004;10:744- 8.
19. Jang Y-Y, Collector MI, Baylin SB et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6:532-9.
20. Wurmser AE, Nakashima K, Summers RG et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004;430:350-6.
21. Kajstura J, Leri A, Finato N et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998; 95:8801-5.
22. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
23. Chin RC-J, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
24. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-9.
25. Taylor DA, Atkins B, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-33.
26. Thompson RB, Emani SM, Davis BH et al. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation 2003;108(suppl): II264-71.
27. Ghostine S, Carrion C, Souza LC et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002;106(suppl):I131-366.
28. Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart: too much of a good thing? Cardiovasc Pathol 2000;9:337-44.
29. Pouly J, Hagege AA, Vilquin J-T et al. Does the functional efficacy of skeletal myoblast transplantation extend to non-ischemic cardiomyopathy? Circulation 2004;110:1626-31.
30. Scorsin M, Hagege A, Vilquin JT et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2002;119:1169-75.
31. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80.
32. Hagege AA, Vilquin J-T, Bruneval P, Menasche P. Regeneration of the myocardium. A new role in the treatment of ischemic heart disease? Hypertension 2001;38:1413-5.
33. Dib N, McCarthy P, Dinsmore J et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: interim analysis from the United States experience [abstract]. Circulation 2002;106(suppl):II463.
34. Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88.
35. Foley A, Mercola M. Heart induction: embryology to cardiomyocyte regeneration [a review]. Trends Cardiovasc Med 2004; 14:121-5.
36. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells from stable intracardiac grafts. J Clin Invest 1996;98:216-24.
37. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108:407-14.
38. Min JY, Yang Y, Converso KL et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002;92:288-96.
39. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes. Role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-40.
40. Boheler KR, Czyz J, Tweedie D et al. Differentiation of pluripotent embryonic stem cells into cardiomyocytes [a review]. Circ Res 2002;91:189-201.
41. Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnology 2004;22:1282-9.
42. Hierlihy AM, Seale P, Lobe CG et al. The post-natal heart contains a myocardial stem cell population. FEBS Letters 2002;530:239-43.
43. Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003;100:10440-5.
44. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
45. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-8.
46. Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1 positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004;279:11384-91.
47. Torella D, Rota M, Nurzynska D et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004;94:514-24.
48. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21.
49. Kawada H, Ogawa M. Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood 2001;98: 2008-13.
50. Issarachai S, Priestley GV, Nakamoto B, Papayannopoulou T. Cells with hemopoietic potential residing in muscle are itinerant bone marrow-derived cells. Exp Hematol 2002;30: 366-73.
51. McKinney-Freeman SL, Jackson KA et al. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 2002;99:1341-6.
52. Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607-12.
53. Lacaud G, Robertson S, Palis J et al. Regulation of hemangioblast development. Ann NY Acad Sci 2001;938:96-108.
54. Otani A, Kinder K, Ewalt K et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002;8:1004-10.
55. Ema M, Faloon P, Zhang WJ et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Develop 2003;17:380-93.
56. Liu YJ, Lu SH, Xu B et al. Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood 2004;103:4449-56.
57. Cogle CR, Wainman D, Jorgensen ML et al. Adult human hematopoietic cells provide functional hemangioblast activity. Blood 2004;103:133-5.
58. Wang LS, Li L, Shojaei F et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004;21:31-41.
59. Botta R, Gao E, Stassi G et al. Heart infarct in NOD/SCID mice: therapeutic vasculogenesis by transplantation of human CD34(+) cells and low dose CD34(+) KDR(+) cells. FASEB J 2004;18:1392-4.
60. Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stem cells differentiate into endothelial cells. Blood 2004;103:13-9.
61. Harrison DE, Astle CM, Lerner C. Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells. Proc Natl Acad Sci USA 1988;85:822-6.
62. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
63. Okada S, Nakauchi H, Nagayoshi K et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706-12.
64. Orlic D, Fischer R, Nishikawa S et al. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 1993;82:762-70.
65. Bodine DM, Seidel NE, Gale MS et al. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994;84:1482-91.
66. Andrews RG, Briddell R, Knitter GH et al. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells. Blood 1994;84:800-10.
67. Laterveer L, Lindley IJ, Hamilton MS et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-75.
68. Pettit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-94.
69. Levesque JP, Hendy J, Takamatsu Y et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-96.
70. Carstanjen D, Ulbricht N, Iacone A et al. Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF. Transfusion 2002; 42:588-96.
71. Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 2002;109:625-37.
72. Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362: 697-703.
73. + hematopoietic stem cells. Blood 2002;99:2037-44.
74. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-7.
75. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275: 964-7.
76. Reyes M, Dudek A, Jahagirdar B et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002;109:337-46.
77. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
78. Edelberg JM, Tang L, Hattori K et al. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 2002;90: E89-93.
79. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7:430-6.
80. Badorff C, Brandes RP, Popp R et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-32.
81. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics [a review]. Circ Res 2004;95: 9-20.
82. Gojo S, Gojo N, Takeda Y et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003;288:51-9.
83. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-9.
84. Huang E, Nocka K, Beier DR et al. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63:225-33.
85. Peled A, Grabovsky V, Habler L et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest 1999; 104:1199-211.
86. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523-30.
87. Kollet O, Spiegel A, Peled A et al. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 2001;97:3283-91.
88. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4.
89. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7.
90. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
91. Davani S, Marandin A, Mersin N et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003;108(suppl): II253-8.
92. Mahmud N, Pang W, Cobbs C et al. Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model. Exp Hematol 2004; 32:494-501.
93. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
94. Xu M, Wani M, Dai Y-S et al. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 2004;110:2658-65.
95. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
96. Airey JA, Almeida-Porada G, Colletti EJ et al. Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation 2004;109:1401-7.
97. Hill JM, Dick AJ, Raman VK et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-14.
98. Karmarkar PV, Kraitchman DL, Izbudak I et al. MR-trackable intramyocardial injection catheter. Magnet Reson Med 2004;51: 1163-72.
99. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003;108:863-8.
100. Devine SM, Cobbs C, Jennings M et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001.
101. Vulliet PR, Greeley M, Halloran SM et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004;363:783-4.
102. Papayannopoulou T, Craddock C, Nakamoto B et al. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995;92:9647-51.
103. Simmons PJ, Masinovsky B, Longenecker BM et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992;80:388-95.
104. Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;423: 302-5.
105. Calvi LM, Adams GB, Weilbrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-6.
106. Hiasa K, Ishibashi M, Ohtani K et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004;109:2454-61.
107. Deten A, Volz HC, Briest W, Zimmer H-G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental study in rats. Cardiovasc Res 2002;55: 329-40.
108. Matsunaga T, Warltier DC, Tessmer J et al. Expression of VEGF, angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol 2003; 285:H352-8.
109. Matsumura G, Miyagawa-Tomita S, Shin'oka T et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729-34.
110. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52.
111. Kawamoto A, Tkebuchava T, Yamaguchi J-I et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461-70.
112. Heyndrickx GR, Baig H, Nellens P et al. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234:H653-9.
113. Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
114. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9.
115. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003;108:2070-3.
116. Norol F, Merlet P, Isnard R et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003;102:4361-8.
117. Murray CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
118. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73.
119. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Med 2004;10:494-501.
120. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
121. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106: 1913-8.
122. Assmus B, Schachinger V, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106:3009-17.
123. Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
124. Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107: 2294-302.
125. Fernandez-Aviles F, Roman JAS, Garcia-Frade J et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-8.
126. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364:141-8.